IN

Incanthera plc

Aquis Stock Exchange

Overview

Corporate Details

ISIN(s):
GB00BGL7YW15 (+1 more)
LEI:
2138002HEV4UFBOEXQ97
Country:
United Kingdom
Address:
C/O GATELEY LEGAL, M2 4WU MANCHESTER
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Incanthera plc is a therapeutics company specializing in the discovery and development of innovative technologies for the dermatology and oncology sectors. The company leverages sophisticated formulation and targeted delivery platforms to create transformative treatment solutions. Its primary commercial focus is on a dermatological skincare range, branded SKIN + CELL, designed to address previously unmet needs in the market. Originating from the Institute of Cancer Therapeutics at the University of Bradford, Incanthera is dedicated to identifying and commercializing novel therapeutics.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Incanthera plc. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-11 08:00
Earnings Release
SKIN + CELL COMMERCIAL WEBSITE NOW OPEN FOR SALES
English 21.4 KB
2025-08-06 08:00
Regulatory News Service
SKIN + CELL TO LAUNCH
English 24.3 KB
2025-07-09 08:00
Major Shareholding Notification
Holding(s) in Company
English 52.6 KB
2025-06-30 08:00
Share Issue/Capital Change
Subscription, Directors' Dealing and RPT
English 51.7 KB
2025-06-18 08:00
Environmental & Social Information
New Findings on Protective Effects of Skin + CELL
English 21.1 KB
2025-03-28 08:00
Regulatory News Service
Commercial Update
English 19.0 KB
2025-03-25 16:08
Legal Proceedings Report
Resolution of Allegations of Patent Infringement
English 19.3 KB

Automate Your Workflow. Get a real-time feed of all Incanthera plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Incanthera plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Biophytis S.A. Logo
Develops oral drugs for age-related neuromuscular, retinal, and metabolic diseases.
France ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and organ repair.
Belgium BIOS
Biosergen AB Logo
Develops innovative therapies for fungal infections in immunocompromised patients.
Sweden BIOSGN
BIOTECH Logo
Biotech group offering preclinical research, gene therapy tech, and human/animal health assets.
Spain BST
Bioversys N Logo
Developing novel drugs to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV
Bonus BioGroup Ltd. Logo
Develops cell therapies and engineered bone grafts for tissue regeneration and inflammation.
Israel BONS
BRAIN Biotech AG Logo
Industrial biotech specialist developing custom enzymes & biosolutions for food & life sciences.
Germany BNN
CAMBRIDGE COGNITION HOLDINGS PLC Logo
Digital brain health assessment platform for CNS clinical trials and research.
United Kingdom COG
Can-Fite BioPharma Ltd. Logo
Develops oral drugs targeting A3AR for oncology, inflammatory, and metabolic diseases.
Israel CANF
Cannabotech Ltd. Logo
Develops botanical medical solutions from cannabinoids & mushrooms for healthcare and wellness.
Israel CNTC